Rob Stein

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 30 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues, and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science, the American Association for Cancer Research, and the Association of Health Care Journalists. He was twice part of NPR teams that won Peabody Awards.

Stein frequently represents NPR, speaking at universities, international meetings and other venues, including the University of Cambridge in Britain, the World Conference of Science Journalists in South Korea, and the Aspen Institute in Washington, DC.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Updated 1:20 p.m. ET

The spread of the coronavirus inside the White House is a stark reminder of the danger of relying on testing to prevent outbreaks, experts say.

"I think the takeaway is clear: Testing alone is not a sufficient strategy to prevent spread of the virus," says Daniel Green, an assistant professor of pathology and cell biology at Columbia University.

"A negative test does not give free license to forgo all other safety measures," Green says.

Updated at 4:30 p.m. ET

The coronavirus can be very serious for anyone at any age but is especially concerning for a man of President Trump's age, 74.

A new generation of faster, cheaper coronavirus tests is starting to hit the market. And some experts say these technologies could finally give the U.S. the ability to adopt a new, more effective testing strategy.

"On the horizon — the not too distant horizon — there are a whole series of testing modalities coming on line," says Dr. Ashish Jha, dean of the Brown School of Public Health. "And that gives us hope we can really expand our testing capacity in the nation."

Copyright 2020 NPR. To see more, visit https://www.npr.org.

SACHA PFEIFFER, HOST:

Dr. Anthony Fauci said Wednesday that he has received death threats and his daughters have been harassed as a result of his high-profile statements about the coronavirus pandemic.

"Getting death threats for me and my family and harassing my daughters to the point where I have to get security is just, I mean, it's amazing," Fauci said.

Pages